RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection
- 7 April 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Applied Biochemistry and Biotechnology
- Vol. 193 (6), 1744-1756
- https://doi.org/10.1007/s12010-021-03548-2
Abstract
Coronavirus disease of 2019 (COVID-19) pandemic, taking place globally, occurs as a result of the SARS-CoV-2 viral infection which has caused death of innumerable numbers of people and is responsible for a massive drop in the global economy. Millions of people are infected, and the death rate is also quite high in different countries. So, there is an urgent requirement of the invention of some effective and efficient drugs that can be effective against this deadly viral infection. The invention of new drugs and vaccine has become a matter of utmost importance to stop the mayhem of coronavirus pandemic. In the middle of such a deadly pandemic, the necessity of development of a vaccine is of high importance in this context. Among all the popular methods of vaccine development, the mRNA vaccines turned out to be the one of the most versatile vaccine with quick responses. However, in this review, we have explained all the possible types of vaccines available including DNA vaccines, RNA vaccines, and live and attenuated vaccines. Their effectiveness, importance, and application of the vaccines against the SARS-CoV-2 virus have been discussed. Research is also being conducted in the field of gene silencing, and one of the best possible ways to combat the virus at the molecular level is by applying RNAi technology. The modified siRNA molecules can be used to silence the gene expression of the virus. A summarization of the virus’s behavior, characteristics, and the methods by which RNAi technology can be administered to control the virus is depicted in this study.Keywords
This publication has 55 references indexed in Scilit:
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon ChallengeJournal of Virology, 2011
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayJournal of Virology, 2011
- Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirionProceedings of the National Academy of Sciences of the United States of America, 2009
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentCell Host & Microbe, 2008
- Supramolecular Architecture of Severe Acute Respiratory Syndrome Coronavirus Revealed by Electron CryomicroscopyJournal of Virology, 2006
- Influence of FcγRIIA and MBL polymorphisms on severe acute respiratory syndromeTissue Antigens, 2005
- Identification of the Murine Coronavirus MP1 Cleavage Site Recognized by Papain-Like Proteinase 2Journal of Virology, 2003
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirusNature, 1984